000 | 00948 a2200277 4500 | ||
---|---|---|---|
005 | 20250517154049.0 | ||
264 | 0 | _c20180403 | |
008 | 201804s 0 0 eng d | ||
022 | _a1872-9061 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWenstedt, E F E | |
245 | 0 | 0 |
_aAcenocoumarol as a risk factor for calciphylaxis: a feature clinicians should be aware of. _h[electronic resource] |
260 |
_bThe Netherlands journal of medicine _cMay 2017 |
||
300 |
_a161-164 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAcenocoumarol _xadverse effects |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
650 | 0 | 4 |
_aCalciphylaxis _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aHuysentruyt, C J | |
700 | 1 | _aKonings, C J A M | |
773 | 0 |
_tThe Netherlands journal of medicine _gvol. 75 _gno. 4 _gp. 161-164 |
|
999 |
_c27189772 _d27189772 |